h Center, George Mason University, Johns Hopkins University School of Medicine, King’s College London, the Massachusetts Institute of Technology (MIT), Michigan State University, National University of Singapore, Northwestern University, The Pennsylvania State University, Stanford University, University of British Columbia, several campuses of the University of California (Berkeley, Irvine, Riverside and San Francisco), University of Florida, University of Illinois at Urbana-Champaign, University of Maryland, University of North Carolina at Chapel Hill, the University of Toronto, University of Virginia, Virginia Tech, and Wake Forest University.
For more information about the ATCC Biomaterial Contributor Network, please visit http://www.atcc.org/bcn.
ATCC is a non-profit mission driven growth business providing quality products and innovative solutions through an organization built on integrity, expertise, and customer centricity. ATCC’s portfolio includes the world’s largest and most diverse collection of human, animal and plant cell lines, molecular genomic tools, microorganisms and bio products serving the scientific community. ATCC’s customers include global academic and government institutions, translational laboratories, pharmaceutical companies, food testing and forensics laboratories, and global public health laboratories. ATCC’s formal mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge.
Read the full story at http://www.prweb.com/releases/2013/8/prweb11061811.htm.
Page: 1 2 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting2
. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations3
. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference4
. ACORN Research, LLC Announces Partnership with AdeptBio, LLC5
. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results6
. WuXi PharmaTech Announces Third-Quarter 2011 Results7
. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting8
. Spherix Announces Third Quarter Financial Results9
. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition10
. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition11
. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint